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Surgical treatment of aortic coarctation has increased life expectancy and reduced mortality. Unfortunately, the average
lifespan after repair remains only 35 to 50 years, and significant morbidity persists as a result of aneurysm formation,
hypertension, accelerated coronary disease, and stroke. Follow-up studies have revealed restenosis rates of 30% and
persistent hypertension at rest and during exercise, sometimes with compromised cardiac function. The less invasive
nature of nonsurgical repair using transcatheter therapies has led to balloon angioplasty and, recently, stent implantation
as an emerging concept for the treatment of aortic coarctation. This review focuses on advances in the management,
current indication, and techniques of interventional repair in aortic coarctation. (J Vasc Surg 2010;51:1550-9.)Advances in surgical treatment of coarctation of the
aorta have increased life expectancy and reduced mortality.
Unfortunately, the average lifespan after open surgical re-
pair remains 35 to 50 years, and significant morbidity
persists as a result of aneurysm formation, hypertens-
ion, accelerated coronary disease, and stroke.1 In addition,
follow-up studies have revealed restenosis rates of 30% and
persistent hypertension at rest and during exercise, often
resulting in compromised cardiac function. The less inva-
sive nature of nonsurgical repair with transcatheter thera-
pies has led to balloon angioplasty and, recently, stent
implantation as an emerging concept for the treatment of
aortic coarctation. Transcatheter studies conducted during
the last 2 decades have focused on the feasibility of treat-
ment and assessing the ability of these devices to reduce the
gradient across the coarctation. This article focuses on
current indications and techniques of interventional repair
in adult aortic coarctation.
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1550INDICATION FOR TREATMENT AND
PATIENT SELECTION
Indications for relief of obstruction, even in asymptom-
atic adult patients, have included clinically determined
radial-femoral arterial pulse delay or a catheter-derived
peak-to-peak gradient of 20 mm Hg at rest or 30 mm
Hg after exercise. However, relief of aortic coarctation may
still be indicated in the presence of lower gradients if
radiologic evidence shows significant collateral flow, left
ventricular dysfunction, or progressive hypertrophy, or if
concomitant anatomic (aortic valve, aortic aneurysm, cor-
onary or carotid atherosclerosis) procedures are being con-
sidered. The benefit and appropriate threshold for inter-
vention is less clear in patients with moderate coarctation,
which usually occurs in the context of a previous surgical
repair. These patients often have significant resting hyper-
tension or may only exhibit hypertension during exercise.
Cardiovascular specialists generally agree that percuta-
neous balloon angioplasty, with or without stent implanta-
tion, is a preferred treatment for recurrent postsurgical
aortic coarctation in the absence of confounding features
such as aneurysm or pseudoaneurysm formation, or signif-
icant coarctation that affects the adjoining arch arterial
branches. However, percutaneous treatment for unoper-
ated aortic coarctation in the adult remains more contro-
versial.2
For localized discrete narrowing of the native aorta,
balloon angioplasty, with or without stent placement, is
now an acceptable alternative to surgical repair as a primary
intervention but is still considered less suitable for long-
segment or tortuous forms of coarctation. Because early
surgical mortality can be 5% to 10% in individuals with
significant comorbidity or severe left ventricular dysfunc-
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therapeutic option in this subgroup of patients. Many
centers now reserve surgery for patients who are unsuitable
for percutaneous treatment or who have undergone unsuc-
cessful endovascular repair.3
NONINVASIVE IMAGING OF AORTIC
PATHOLOGY BEFORE INTERVENTION
Before endovascular therapy for aortic coarctation,
each patient requires a detailed assessment of the anatomy
and physiologic pattern of the obstruction and associated
lesions. In practice, this includes complete visualization of
the aorta and its branches by contrast-enhanced magnetic
resonance (MR) angiography (MRA) or computed tomog-
raphy (CT) scan. Although indications may overlap, both
imaging modalities allow detailed delineation of vascular
pathology by dedicated postprocessing routines, including
3-dimensional (3D) reconstruction, multiplanar reforma-
tion, or maximum-intensity projection. A 3D reconstruc-
tion can identify the precise location and complex anatomy
of coarctation and demonstrates its relationship to supra-
aortic branches, presence of isthmus hypoplasia, and the
extent of collateral networks (Fig 1). Reformatted images
in any desired plane can be used to obtain precise measure-
ments of the aorta for therapeutic decision making before
cardiac catheterization. The obvious advantages of multi-
detector CT include rapid image acquisition and its poten-
tial to screen for vascular calcification, whereas MRA is
often preferred in young patients who will require multiple
follow-up examinations because it offers high spatial reso-
lution to characterize aortic wall properties but avoids
Fig 1. Noninvasive assessment of aortic pathology in
rendered images obtained from a 64-slice multidetecto
including discrete aortic narrowing (arrow) and hypopl
Note the detailed display of the collateral network and a
the right internal mammarian arteryradiation and iodinated contrast agents.EQUIPMENT FOR CATHETER-BASED
INTERVENTIONS
With improvements in technology, various endovascu-
lar stents have become available for the treatment of coarc-
tation (Fig 2). Stents may generally be subdivided into
balloon-expanded or self-expanding devices, with covered
stents recently added to the therapeutic armamentarium. In
1999, the United States Food and Drug Administration
(FDA) approved the Palmaz XL 10-series stents (Cordis,
Endovascular, Miami, Fla), ranging up to 50 mm in length.
These stents made it possible to deliver long stents to the
thoracic aorta that could be expanded later with growth of
the aorta to a maximum diameter of 25 to 28mm. They are
laser cut from a very rigid stainless steel tube, with straight
slits interpolated along the length of the stent. The Palmaz
XL stents form a very strong closed diamond shape when
the stent is expanded, except at the ends of the stent, with
alternating open half-diamond stent cells. These stents
demonstrate significant shortening by almost 50% when
expanded to their full diameter.
The Palmaz Genesis XD stent (Cordis Endovascular,
Miami, FL) is also laser cut from stainless steel and has a
closed-cell design; however, it has a S-shaped sigma hinge
interposed between the cells, which allows the stent to flex
around curves and reduces shortening on expansion. The
Genesis stents are available in multiple lengths but cannot
be expanded further than 18 to 20 mm. Unless the aorta is
expected to reach a diameter significantly greater than 18
mm, the radial strength and flexibility of the Genesis stent
make it an excellent option for treatment of lesions that lie
across the curve between the transverse arch and the de-
ient with severe coarctation. A composite of volume-
angiogram is presented. A, Classic anatomic features
ortic arch are clearly visualized in lateral projection. B,
mitant ectasia of the ascending aorta (ASC). *Indicatesa pat
r CT
astic a
concoscending aorta.
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less steel balloon-expandable stent covered with expanded
polytetrafluoroethylene. The stent has an expansion range
of 10 to 18 mm and retains the features of the first Genesis
stents, such as the possibility of insertion in curved vessels
with good radial strength. Palmaz stents, with their closed-
cell design, have essentially no flexibility at all and will fail to
conform to the contour of the aortic arch.
The Palmaz XL 10 series remained the only large stents
available until the IntraStent LDMaxTM stent (ev3 Endo-
vascular Inc, Plymouth,Minn) was approved in 2002.With
an open-cell design that significantly reduces stent shorten-
ing and rounded cell edges at the ends, these stents offer
advantages over the Palmaz stents. However, the stent may
take less purchase in the vessel wall during deployment
because of its rounded edges, making it, at least theoreti-
cally, more prone to migration, especially in lesions with a
higher degree of compliance. The ev3 stents can be en-
Fig 2. A selection of endovascular devices are current
A, The CP stents by NuMed are made of platinum wire w
shortening and good radial strength. B, The ev3 Intraste
significantly shorten. C, The “sigma’’ hinge in the Gene
significant shortening on expansion; however, these ste
Balloon-in-Balloon catheter allows even expansion of
positioning.larged to 24 to 26mm and have radial strength only slightlyless than the Palmaz stents at this diameter; lengths of 16,
26, and 36 mm are available.
Cheatham-Platinum (CP) stents (NuMED Inc, Hop-
kinton, NY) are not yet available in the United States but
have been used extensively in Europe, with apparent suc-
cess. The balloon-expandable stents are made of a frame-
work of platinum-iridium wire laser-welded in a zig-zag
pattern with additional gold soldering to each weld spot to
add extra strength. With its rounded margins, the CP stent
is designed tominimize aortic wall trauma. The CP covered
stent, currently not available in the United States, is a
balloon-expandable stent with an expanded polytetrafluo-
roethylene sleeve. This stretches with the stent to its max-
imum diameter of 24 mm, and this may be accompanied by
a foreshortening of up to 40% of the initial length of the
stent.
The OptiMed Sinus-XL stent (OptiMed, Ettlingen,
Germany) is a self-expanding nitinol (shape-memory) stent
ilable for the transcatheter repair of adult coarctation.
ows of zigzags to allow full-size expansion with minimal
ax LD is expandable to full size, is flexible, and does not
nts allows the stents to flex around curves and prevents
annot be expanded beyond 18 mm. D, The NuMED
and-mounted stent for safer and more reliable stently ava
ith r
nt M
sis ste
nts c
a hthat is laser cut without welding. It was designed with
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is appropriate for deployment in fibrous, calcified lesions,
and the absence of foreshortening allows precise coverage
(Fig 3).
One of the most important technical refinements for
delivery of large-diameter stents has been the NuMED
Balloon-in-Balloon (BIB) catheter (Fig 2). These catheters
have an inner balloon and a longer outer balloon that is
double the diameter of the inner balloon and are available
in outer-balloon sizes of up to 24 mm. They offer the
important advantage of opening the stent more uniformly
along its length, thereby eliminating the risk of unintended
stent protrusion that has been documented by the use of
single balloons. BIB catheters require a larger arterial
sheath for introduction, however, which needs to be
upsized by 1F if a hand-crimped balloon is mounted on
the balloon. Thus, although BIB catheters prevent stent
flare and offer more precise control over stent placement,
Fig 3. Serial aortograms in the left oblique projection
(B) predilatation angioplasty, (C) implantation of a 28-
tation angioplasty. E, Significant increase in isthmus diam
reconfirmed (F) by computed tomography angiographysingle-balloon catheters are still sometimes preferable insmaller patients to reduce the risk of femoral artery injury
at the access site.
TRANSCATHETER APPROACH FOR REPAIR
OF ADULT COARCTATION
Basic technique for stent placement. There are var-
ious descriptions of delivery techniques to the central aorta
in patients selected for transcatheter repair of adult coarc-
tation.4 Procedures are routinely performed under local
anesthesia and sedation in a cardiac catheterization labora-
tory with dedicated fluoroscopic guiding capabilities. Once
the percutaneous access to the femoral artery is established,
intravenous heparin is administered to keep activated clot-
ting time 250 seconds.
A pigtail or multipurpose catheter with a Terumo
0.035-inch hydrophilic wire is advanced to navigate
through the coarctation. Once the pigtail catheter reaches
ict (A) severe primary coarctation before angioplasty,
elf-expanding nitinol Sinus-XL stent, and (D) postdila-
from 3 to 24 mm is seen in the final aortogram and was
nths after stent deployment.dep
mm s
eter
3 mothe proximal ascending aorta, an angiogram is performed in
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After delineation of vascular anatomy, a stiff wire is passed
retrogradely across the coarctation with the aid of an atrau-
matic guiding catheter, with the soft tip of this wire located
deeply in the left subclavian artery or in the ascending aorta.
In lesions of the transverse arch, the wire position in the
ascending can help to keep the balloon and stent straight,
whereas lesions in the descending aorta may benefit from
stenting with the wire in the left subclavian artery. Gener-
ally, the stiff wire forms a rigid track for stabilization of the
balloon and stent during deployment. In subatretic, heavily
calcified, or recurrent lesions, stepwise predilatation angio-
plasty might become necessary, whereas one should gener-
ally try to avoid unprotected predilatation to reduce the
inherent risk of consecutive wall injuries. Moreover, a
technique for snaring and externalizing the distal end of the
wire from the right brachial artery to form a very stable
“railway’’ for use in the stent delivery can be applied in
difficult cases (Fig 4).5
Once the appropriate stent and delivery balloon are
selected, the stent must be carefully hand-crimped onto
the balloon, and a long arterial sheath of the appropriate
size can be exchanged over the wire for proper delivery of
the stent. The sheath is then advanced across the coarcta-
tion by road mapping assistance. Choice of a balloon that is
Fig 4. Schematic representation of the “arterial railway.” An
extra-stiff guidewire is advanced from the femoral artery to the
right subclavian artery. This wire is snared in the innominate artery,
exteriorized through the right brachial sheath, and fixed in place
with a hemostat clamp at both ends. The railway provides an
extremely stable platform, allowing minimal movement of the
balloon/stent assembly during deployment. This strategy may
decrease the risk of stent malposition and could be particularly
useful in anatomically complex cases.barely longer than the stent, establishment of a stable wireposition that keeps the stent straight during deployment,
and use of a BIB catheter will generally prevent technical
complications such as balloon rupture and stent migration.
Before the balloon is inflated, it is recommended to
decrease stroke volume by rapid right ventricular pacing to
prevent device displacement from pulsatile cardiac forces.
The inner balloon of the BIB catheter is inflated, and an
angiogram can be performed through the sheath or
through an anterograde catheter in the proximal aorta to
confirm position of the stent. With the stent in the desired
position, the outer balloon is inflated to fix the stent in the
lesion. Once the stent is expanded, both the outer and
inner balloons are deflated as rapidly as possible, and RV
pacing is terminated.
The balloon catheter is removed and the pigtail cathe-
ter can be advanced over the wire to the area just proximal
to the stent, to perform a repeat angiogram and assess stent
position and size and check for signs of vascular complica-
tions. A pullback should be repeated to document any
residual poststent gradient. Gentle postdilatation with an
appropriately sized low-pressure balloon should be per-
formed to abolish any residual gradient; diameter reduction
by 50% should also be followed by balloon molding to
obtain satisfactory results even though any gradient had
disappeared.
Of note, accumulated data suggest that both aggressive
prestent angioplasty and repeated postdilatation of the
stent contribute to the overall risk of aortic wall injury.6-8
Patient age also appears to be an important risk factor for
major complications, particularly if the aorta is calcified
with reduced resilience to expansion.9 In consequence, it
may be more prudent to aim for hemodynamic success
rather than immediate angiographic resolution of the ste-
nosis in those patients (Fig 5).
Oversizing of balloons should generally be avoided,
and our practice is not to try to flare the stent ends to fully
oppose the stent to the aortic wall because this often
requires the use of a larger balloon. Whether nonadherence
of the stent at the proximal and distal ends will be of any
long-term consequence is unknown at present. Stent over-
lap of brachiocephalic vessels may constitute a theoretic risk
but is technically unavoidable in certain cases of transverse
arch or proximal isthmic obstruction.
Self-expandable stent for adult coarctation. Self-
expanding elastic stents with moderate radial forces are
highly likely to accommodate both compliance and func-
tional integrity of the diseased aorta, considering that both
classic surgery and implantation of stiff balloon-mounted
stents markedly alter the biologic properties of the aortic
wall. Conversely, self-expanding stents expose the coarcta-
tion segment to the gentle but constant radial force of
nitinol, a process likely to create less local trauma evenwhen
adjunctive low pressure is applied after dilation. Stenting
with self-expanding devices works by stretching and scaf-
folding rather than tearing the aorta, which may account
for the observed lower short-term instances of aortic wall
complications.
e sten
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reported on the application of self-expandable stents for
transcatheter repair of aortic coarctation. In the Tyagi et
al10 report, self-expanding nitinol stents were deployed in
16 patients without periprocedural aortic wall complica-
tions. Authors from the Teheran Heart Center recently
Fig 5. Implantation of a 39-mm covered Cheatham
coarctation. A, Composite of two frames of the same ang
in two steps: (B) first, the stent was implanted with only m
the stent was definitively dilated to completely relieve th
Fig 6. Delivery of a covered stent inside a previously
angiogram after stent deployment demonstrates occ
recannulization of the left subclavian artery, perforatio
followed by dilation with a coronary balloon. C, Postp
to the left subclavian artery.confirmed this observation. No aortic wall injuries weredocumented in their series of 21 patients treated with
self-expanding nitinol stents.11 In our unpublished series of
31 patients, precise placement of a flexible Sinus-Aorta
nitinol stent was successful in all cases and no wall compli-
cations were documented (Fig 3). On aggregate, prelimi-
nary data suggest that transcatheter repair of primary aortic
um (CP) stent for the treatment of subatretic aortic
m (early and late phase). The procedure was performed
rate dilatation of the subatretic area; (C) after 6 months,
osis.
anted bare stent is shown. A, A Left anterior oblique
n of flow to the left subclavian artery. B, During
a covered stent with the stiff end of coronary wire was
ural angiogram shows excellent result, with brisk flowplatin
iogra
odeimpl
lusio
n of
rocedcoarctation with self-expanding nitinol stents is highly ef-
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aortic conditions.
Application of covered stents. Covered stents have
been used to address problems associated with aortic wall
injury by balloon angioplasty and bare stent placement.
They are preferentially placed in patients with an aortic wall
aneurysm, with a tight primary coarctation and risk of
rupture, in the presence of an associated arterial duct, and
in older patients in whom the vessel wall is barely compli-
ant.12-15 As was recently demonstrated, serial repeat dilata-
tion of an underdeployed covered stent is feasible and can
be considered as a strategy for adult coarctation in which
there is a concern that deployment to a normal size may
result in aortic rupture.16 Given the reported cases of aortic
dissections and rupture, covered stents should be readily
available in the catheterization laboratory for undelayed
treatment of vascular emergencies potentially complicating
transcatheter repair.6,17,18 The placement of endovascular
stent grafts has also been considered a valuable therapeutic
option for aneurysms forming late after surgical repair of
aortic coarctation.19 The main challenges with a covered
Table I. Outcome after bare stent implantation for adult
Study, year
Pts.
No.
Native
CoA
No.
Mean
age,
years Follow-up
Press
gradi
mm
Before
Chessa,7 2005 71 52 22 Median, 36
mo
39  15
Mahadevan,28
2006
35 24 31 12 mo for
22 pts.
28  15
Thanopoulos,27
2008
46 25 33 60 mo for
all pts
58  17
Haji-Zeinali,11
2009
21 19 19 16  12;
median,
14
57  20
CoA, Coarctation; BA, balloon angioplasty; BES, balloon-expandable stent;
coarctation; SES, self-expending stent.stent are attributed to larger sheath size and potentialocclusion of supra-aortic branches. Occlusion of the left
subclavian artery is well tolerated; however, an intact verte-
brobasilar system should be documented before the proce-
dure.20 Although coverage of arterial branches is undesir-
able, modification strategies exist to restore native flow,
including flaring of the end of the stent into the affected
vessel or dilation of graft material through stent cells21
(Fig 6).
PROCEDURAL RISKS AND POTENTIAL
COMPLICATIONS
Intraprocedural deaths related to aortic rupture and
dissection appear to be very infrequent,2,8 but complica-
tions do occur after stent placement. In particular, various
authors have observed devicemigration and vascular injuries
at the site of arterial cannulation. In amulti-institutional registry
encompassing 588 procedures from 1989 to 2005,8 stent
migration was documented in 4.8%. Migration is com-
monly believed to result from balloon oversizing and un-
dersizing or is considered a sequela of balloon rupture.
Stent fractures were rarely documented (1.0%), but a sec-
tation
Procedural
complication
Adjunctive
procedures Commentser
6 8.40% 5.60% BES; 30-day
mortality: 1.4%;
no late death
3 stent migration 2 BA for
ReCoA
1 aortic hematoma 1 CS for
Re-CoA
2 femoral PSA 1 CS for
ReCoA/An
4 20.00% 8.60% BES; no early or late
death; BP reduced
from 142  79 to
125  71 at 12
mo
2 stent migration 3 BA for
residual CoA
2 minor stroke
3 aortic wall compl
5 4.30% 43.40% BES; no early or late
death
1 stent migration 20 BA for
residual
CoA:
1 femoral PSA serial dilatation
concept
2 14.30% 4.80% SES; no early or late
death; BP reduced
from 160  23 to
128  8 at 12 mo
3 stent migration 1 SES for
ReCoA
lood pressure; CS, covered stent; PSA, pseudoaneurysm; ReCoA, recurrentcoarc
ure
ent,
Hg
Aft
4 
4 
7 
1 
BP, bond stent for recurrent obstruction was required in most
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death has been recently reported from experienced cen-
ters,22 and we are aware of acute dissection in 1.6% of
patients treated endovascularly for aortic coarctation.8
Therefore, covered stents should be readily available in the
cardiac catheterization laboratory, as should onsite surgical
support to facilitate urgent treatment of vascular emergen-
cies complicating endoluminal procedures.
With respect to access site, a 2.6% incidence of femoral
artery injuries was reported. Recently, peripheral vascular
complications have been reduced by using closure devices,
with immediate hemostasis almost always achieved, even in
heparinized patients. Cerebrovascular accidents have been
documented in1% of patients after transcatheter repair of
coarctation. Although the exact etiology of cerebrovascular
complications remains speculative in most cases, they have
been related to technical complications, such as stent mi-
gration, balloon rupture, aortic dissection, and rupture, as
well as progressive atheromatous disease in elderly hyper-
tensive patients.8
IMMEDIATE AND LONG-TERM RESULTS
AFTER TRANSCATHETER REPAIR
Although gradient reduction after balloon dilatation is
generally acceptable, the procedural outcome is suboptimal
in up to 9% of patients, with a gradient of ’20 mmHg.23,24
Interestingly, restenosis in adult patients who have been
treated with balloon dilation is relatively rare when the
gradient has been reduced to10 mmHg after the proce-
dure.25,26 Late aneurysm formation has been documented
in up to 20% of patients in initial series but most remain
hemodynamically insignificant and are followed up conser-
vatively. In contrast to primary coarctation, reported out-
comes on balloon angioplasty have been less favorable in
patients treated for recurrent stenosis after previous open
repair.
Stenting has rapidly become the mainstay of endovas-
cular treatment for adult coarctation in many institutions,
with nearly complete resolution of gradients in both unop-
erated and recurrent stenotic lesions (Table I). Theoreti-
Table II. Results after adult coarctation repair with covere
Study
Pts.
No.
Age
years
Native
CoA
No.
Aneurysm
formation
No.
Pr
Befo
Tzifa,31 2006 30 28  18 14 8 36 
Butera,32 2008 33 6-66 20 2 20-75,
media
Tanous,33 2008 22 39  14 14 6 29 
Bruckheimer,16
2009
22 8-39 22 0 29 
CoA, Coarctation of the aorta.cally, stent implantation may overcome some of the short-comings of balloon dilatation for aortic coarctation because
the metal scaffolding can reduce the incidence of acute
elastic recoil as well as late restenosis due to more complete
elimination of gradient in the high-velocity-flow arterial
system.7,11,27,28 Another potential benefit with primary
stent implantation is the ability to address longer segment
coarctations, which typically have a poorer outcome after
balloon angioplasty alone. Stents may also reduce the inci-
dence of residual intimal tears and subsequent aneurysm
formation by allowing both the use of smaller dilation
balloons as well as graded inflations in staged procedures.
Although follow-up with detailed imaging of the
stented area is often incomplete in the published series, it
appears from the available data that aneurysm formation
occurs in 5% of patients after this procedure.29 A recent
large multi-institutional study addressed the procedural
and intermediate-term outcomes in nearly 600 patients
aged4 years. Procedural success with predominantly bare
metal stents was 98%, acute complications occurred in 14%,
and there were two procedurally related deaths.8
Today, some authors emphasize the role of covered
stents as a preferred strategy for endovascular repair in adult
coarctation.30 Covered stents have been used in the treat-
ment of primary and recurrent coarctation with apparent
success, including in older patients with challenging anat-
omy (Table II). The rate of recoarctation is low despite
many of the individuals in these studies having undergone
prior surgical and interventional procedures; thus far, an-
eurysm formation has not been detected at intermediate-
term follow-up.16,31-33
Generally, endovascular relief of coarctation gradients
results in a profound reduction in ambulatory blood pres-
sure,34 with demonstrable reductions in left ventricular
mass35 and improvement in left ventricular functional indi-
ces.36 However, despite some reduction in blood pressure,
up to one-third of patients will remain hypertensive after
endovascular repair, and left ventricular dysfunction is not
completely abolished in all cases.37-39 Persistent hyperten-
sion after coarctation repair results from an interplay of
several factors, including recoarctation, endothelial dys-
nts
gradient,
Hg
Aortic complications
Restenosis or
serial redilationAfter
4  4 Dissection, spontaneously
resolved (n  1)
4 (serial dilatation)
0-12,
median 0
None 1
3  5 Aortic tear treated with
an additional covered
stent (n  1)
3
7  7 Aortic tear treated with
an additional covered
stent (n  1)
9 (serial dilatation)d ste
essure
mm
re
20
n 39
17
9function, arch morphology, and vascular and ventricular
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long-term prevention of vascular disease in patients with
repaired coarctation.
CONCLUSIONS
Treatment of coarctation of the aorta with balloon
angioplasty or endovascular stents may be technically chal-
lenging, but it is relatively safe and extremely effective when
used carefully in appropriate patients. Further research that
includes universal follow-up imaging is necessary to deter-
mine the incidence of complications and the nature of risk
factors. At present, in the absence of randomized trials, it is
premature to conclude that stent implantation is generally
superior to balloon dilation in moderate-to-severe coarcta-
tion and recoarctation. Nevertheless, in view of the favor-
able short-term and intermediate-term results, stent im-
plantation is rapidly becoming the preferred treatment
option for adult coarctation. Long-term results are being
awaited.
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